AGRX - Agile Therapeutics

Industry: Drugs - Generic Sector: Healthcare | Exchange: NASDAQ

Buy Candidate
Thu 21'st Sep 2017

PERIOD 2017-06-22 - 2017-09-21
CHANGE 1.07%
PRICE $3.77





Request Prediction

Agile Therapeutics Stock Analysis

Technical stock analysis for Thu 21'st Sep 2017

Buy candidate since 2017-09-19 Gain 3.86%

Agile Therapeutics gained 1.07% in the last trading day, rising from $3.73 to $3.77 , and has now gained 3 days in a row. It will be exciting to see whether it manages to continue gaining or take a minor break for the next few days. The price has risen in 7 of the last 10 days and is up by 11.21% over the past 2 weeks. Volume has increased in the last day along with the price, which is a positive technical sign, and, in total, 36 744 more shares were traded than the day before. In total, 156 542 shares bought and sold for approximately $590 163.


Agile Therapeutics lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -13.73% during the next 3 months and, with 90% probability hold a price between $2.35 and $4.17 at the end of this period.


Only positive signals in the chart today. Agile Therapeutics holds buy signals from both short- and long-term moving averages. In addition, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down there will be some support from the lines at $3.71 and $3.44. A break down below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Tuesday September 19, 2017, which indicates further gains until a new top pivot has been found. Agile Therapeutics has rising volume and follows the last lift in the price. This is considered to be a technical positive sign as volume should follow the price-formation. Higher liquidity also reduces the general risk.

Relative Strength Index (RSI)

RSI14 is 66 and the stock is currently not being overbought or oversold

Support & Resistance

Agile Therapeutics finds support from accumulated volume at $3.76. On the upside the stock meets some resistance just above today's level from accumulated volume at $3.83, $3.84 and $4.60.

The stock is about to test the resistance from accumulated volume at $3.83 and this may cause the stock to take a minor break or get into a more sideways move for a few days.

Support: $3.76 Price: $3.77 Resistance: $3.83
S: $3.76 Price: $3.77 R: $3.83


This stock may move much during a day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.13 between high and low, or 3.55%. For the last week, the stock has had a daily average volatility of 4.69%.

Our recommended stoploss: $3.59 (-4.86%) (This stock has medium daily movements and this gives medium risk. There is a buy signal from pivot bottom found 2 days ago.)

Overall risk:

Very Low Low Medium High Very High

Overall risk:



Several short-term signals are positive, despite the stock being in a falling trend, we conclude that the current level may hold a buying opportunity as there is a fair chance for this stock to perform well in the short-term.

Buy Candidate

Trade AGRX CFDs with Plus500

Your capital is at risk.

Important: Plus500 doesn't offer signals and it is a CFD service. Plus500UK Ltd is authorised and regulated by the Financial Conduct Authority (FRN 509909).

Help StockInvest improve by answering this short survey clicking HERE.

Build Your Watchlist

Add AGRX My Watchlist

books of the week

Last donation

Do you find our website useful too?
Help us improve by making a small donation or
Get PRO features

Sign up to get FREE access to awesome features

Auto-portfolios that gain up to 30%

Request predictions from other users

Watchlist builder with notifications

News updates from 100+ financial publications